Literature DB >> 17578852

New mutations, genotype phenotype studies and manifesting carriers in giant axonal neuropathy.

Henry Houlden1, Mike Groves, Zosia Miedzybrodzka, Helen Roper, Tracey Willis, John Winer, Gaynor Cole, Mary M Reilly.   

Abstract

Giant axonal neuropathy (GAN; MIM 256850) is a severe childhood onset autosomal recessive sensorimotor neuropathy affecting both the peripheral nerves and the central nervous system. Bomont and colleagues identified a novel ubiquitously expressed gene they named Gigaxonin on chromosome 16q24 as the cause of GAN in a number of families. We analysed five families with GAN for mutations in the Gigaxonin gene and mutations were found in four families; three families had homozygous mutations, one had two compound heterozygous mutations and one family had no mutation identified. All families had the typical clinical features, kinky hair and nerve biopsy. We report some unusual clinical features associated with GAN and Gigaxonin mutations as well as confirm the heterogeneity in GAN and the identification of two families with manifesting carriers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17578852      PMCID: PMC2117591          DOI: 10.1136/jnnp.2007.118968

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  15 in total

1.  Identification of seven novel mutations in the GAN gene.

Authors:  P Bomont; C Ioos; C Yalcinkaya; R Korinthenberg; J M Vallat; S Assami; A Munnich; B Chabrol; G Kurlemann; M Tazir; M Koenig
Journal:  Hum Mutat       Date:  2003-04       Impact factor: 4.878

2.  Giant axonal neuropathy.

Authors:  B O Berg; S H Rosenberg; A K Asbury
Journal:  Pediatrics       Date:  1972-06       Impact factor: 7.124

3.  Giant axonal neuropathy--a unique case with segmental neurofilamentous masses.

Authors:  A K Asbury; M K Gale; S C Cox; J R Baringer; B O Berg
Journal:  Acta Neuropathol       Date:  1972       Impact factor: 17.088

4.  Gene targeting of GAN in mouse causes a toxic accumulation of microtubule-associated protein 8 and impaired retrograde axonal transport.

Authors:  Jianqing Ding; Elizabeth Allen; Wei Wang; Angela Valle; Chengbiao Wu; Timothy Nardine; Bianxiao Cui; Jing Yi; Anne Taylor; Noo Li Jeon; Steven Chu; Yuen So; Hannes Vogel; Ravi Tolwani; William Mobley; Yanmin Yang
Journal:  Hum Mol Genet       Date:  2006-03-24       Impact factor: 6.150

5.  Spine deformities in Charcot-Marie-Tooth 4C caused by SH3TC2 gene mutations.

Authors:  H Azzedine; N Ravisé; C Verny; A Gabrëels-Festen; M Lammens; D Grid; J M Vallat; G Durosier; J Senderek; S Nouioua; T Hamadouche; A Bouhouche; A Guilbot; C Stendel; M Ruberg; A Brice; N Birouk; O Dubourg; M Tazir; E LeGuern
Journal:  Neurology       Date:  2006-08-22       Impact factor: 9.910

6.  The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy.

Authors:  P Bomont; L Cavalier; F Blondeau; C Ben Hamida; S Belal; M Tazir; E Demir; H Topaloglu; R Korinthenberg; B Tüysüz; P Landrieu; F Hentati; M Koenig
Journal:  Nat Genet       Date:  2000-11       Impact factor: 38.330

7.  Giant axonal neuropathy (GAN): case report and two novel mutations in the gigaxonin gene.

Authors:  G Kuhlenbäumer; P Young; C Oberwittler; G Hünermund; A Schirmacher; K Domschke; B Ringelstein; F Stögbauer
Journal:  Neurology       Date:  2002-04-23       Impact factor: 9.910

8.  Cerebral proton magnetic resonance spectroscopy of a patient with giant axonal neuropathy.

Authors:  Knut Brockmann; Petra J W Pouwels; Peter Dechent; Kevin M Flanigan; Jens Frahm; Folker Hanefeld
Journal:  Brain Dev       Date:  2003-01       Impact factor: 1.961

9.  Giant axon and neurofilament accumulation in Charcot-Marie-Tooth disease type 2E.

Authors:  G M Fabrizi; T Cavallaro; C Angiari; L Bertolasi; I Cabrini; M Ferrarini; N Rizzuto
Journal:  Neurology       Date:  2004-04-27       Impact factor: 9.910

10.  Clinical and molecular findings in patients with giant axonal neuropathy (GAN).

Authors:  C Bruno; E Bertini; A Federico; E Tonoli; M L Lispi; D Cassandrini; M Pedemonte; F M Santorelli; M Filocamo; M T Dotti; A Schenone; A Malandrini; C Minetti
Journal:  Neurology       Date:  2004-01-13       Impact factor: 9.910

View more
  8 in total

1.  Target-enrichment sequencing and copy number evaluation in inherited polyneuropathy.

Authors:  Wei Wang; Chen Wang; D Brian Dawson; Erik C Thorland; Patrick A Lundquist; Bruce W Eckloff; Yanhong Wu; Saurabh Baheti; Jared M Evans; Steven S Scherer; Peter J Dyck; Christopher J Klein
Journal:  Neurology       Date:  2016-04-13       Impact factor: 9.910

Review 2.  "Personalizing" academic medicine: opportunities and challenges in implementing genomic profiling.

Authors:  David J Tweardy; John W Belmont
Journal:  Transl Res       Date:  2009-10-06       Impact factor: 7.012

3.  Modest loss of peripheral axons, muscle atrophy and formation of brain inclusions in mice with targeted deletion of gigaxonin exon 1.

Authors:  Florence Dequen; Pascale Bomont; Geneviève Gowing; Don W Cleveland; Jean-Pierre Julien
Journal:  J Neurochem       Date:  2008-07-31       Impact factor: 5.372

4.  Giant axonal neuropathy: a multicenter retrospective study with genotypic spectrum expansion.

Authors:  Andoni Echaniz-Laguna; Jean-Marie Cuisset; Lucie Guyant-Marechal; Patrick Aubourg; Laurent Kremer; Naziha Baaloul; Alain Verloes; Kouider Beladgham; Jimmy Perrot; Bruno Francou; Philippe Latour
Journal:  Neurogenetics       Date:  2019-10-26       Impact factor: 2.660

5.  Gigaxonin controls vimentin organization through a tubulin chaperone-independent pathway.

Authors:  Don W Cleveland; Koji Yamanaka; Pascale Bomont
Journal:  Hum Mol Genet       Date:  2009-01-24       Impact factor: 6.150

Review 6.  Processing of nerve biopsies: a practical guide for neuropathologists.

Authors:  Joachim Weis; Sebastian Brandner; Martin Lammens; Claudia Sommer; Jean-Michel Vallat
Journal:  Clin Neuropathol       Date:  2012 Jan-Feb       Impact factor: 1.368

7.  Sensory-motor deficits and neurofilament disorganization in gigaxonin-null mice.

Authors:  Thibault Ganay; Alexia Boizot; Renaud Burrer; Jean Paul Chauvin; Pascale Bomont
Journal:  Mol Neurodegener       Date:  2011-04-12       Impact factor: 14.195

8.  Development of Intrathecal AAV9 Gene Therapy for Giant Axonal Neuropathy.

Authors:  Rachel M Bailey; Diane Armao; Sahana Nagabhushan Kalburgi; Steven J Gray
Journal:  Mol Ther Methods Clin Dev       Date:  2018-02-15       Impact factor: 6.698

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.